Oral Wegovy vs Compounded Semaglutide: Which Wins?

The Wegovy pill and compounded injectable semaglutide both use the same active ingredient. But the similarities end there. Here's a direct comparison.

Head-to-Head

Factor	Oral Wegovy	Compounded Injectable
Active ingredient	Semaglutide	Semaglutide
FDA-approved	Yes	No (as finished product)
Monthly cost	$149	$130-300
Dosing	Daily pill	Weekly injection
Weight loss	16.6%	~15% (based on branded trial data)
Refrigeration	Not needed	Depends on formulation
Needles	None	Yes (self-administered)
Regulatory risk	None	Moderate (FDA tightening)
Insurance eligible	Yes (some plans)	Rarely

When Oral Wegovy Wins

• You want FDA-approved medication with full regulatory certainty
• You're needle-averse
• You travel frequently (no cold chain)
• You have insurance that covers brand-name GLP-1s
• You want the most consistent dosing (pre-measured tablet)

When Compounded Wins

• You prefer once-weekly dosing over daily pills
• You can't manage the 30-minute empty stomach requirement
• You're at a dose that makes compounded cheaper (some low-dose plans start at $130)
• You want injectable formulation for higher bioavailability

The Bottom Line

Oral Wegovy is the default recommendation for patients who prioritize regulatory certainty, convenience, and cost predictability. Compounded injectables remain viable for those who prefer weekly dosing or are already established on an injectable regimen. The cost difference between the two has narrowed to the point where convenience and preference — not price — should drive the decision.